Regarding the controversial issue linking mutations of the 3′ end of the BRCA1 to lower incidence of ovarian cancer, our data show that ovarian cancer is indeed lower when mutations inflict the 3′ end of the BRCA1 gene. This evidence concerns the gene BRCA1 and ovarian carcinoma.